These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18297137)

  • 21. Human stem cell therapy in ischaemic stroke: a review.
    Banerjee S; Williamson D; Habib N; Gordon M; Chataway J
    Age Ageing; 2011 Jan; 40(1):7-13. PubMed ID: 21071454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance P expression by human dental pulp fibroblasts: a potential role in neurogenic inflammation.
    Killough SA; Lundy FT; Irwin CR
    J Endod; 2009 Jan; 35(1):73-7. PubMed ID: 19084129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptides in dental pulp: the silent protagonists.
    Caviedes-Bucheli J; Muñoz HR; Azuero-Holguín MM; Ulate E
    J Endod; 2008 Jul; 34(7):773-88. PubMed ID: 18570980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complexity of neurobiological processes in acute ischemic stroke.
    Brouns R; De Deyn PP
    Clin Neurol Neurosurg; 2009 Jul; 111(6):483-95. PubMed ID: 19446389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
    Birklein F; Schmelz M
    Neurosci Lett; 2008 Jun; 437(3):199-202. PubMed ID: 18423863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased substance P immunoreactivity and edema formation following reversible ischemic stroke.
    Turner RJ; Blumbergs PC; Sims NR; Helps SC; Rodgers KM; Vink R
    Acta Neurochir Suppl; 2006; 96():263-6. PubMed ID: 16671467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurogenic pulmonary edema.
    Baumann A; Audibert G; McDonnell J; Mertes PM
    Acta Anaesthesiol Scand; 2007 Apr; 51(4):447-55. PubMed ID: 17378783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome.
    Thal SC; Sporer S; Schmid-Elsaesser R; Plesnila N; Zausinger S
    Crit Care Med; 2009 Jul; 37(7):2228-34. PubMed ID: 19487935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation, plasticity and real-time imaging after cerebral ischemia.
    Kriz J; Lalancette-Hébert M
    Acta Neuropathol; 2009 May; 117(5):497-509. PubMed ID: 19225790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacology of neuroprotection in acute ischemic stroke].
    Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
    Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The functional anatomy of cerebral reorganisation after focal brain injury.
    Ward NS; Frackowiak RS
    J Physiol Paris; 2006 Jun; 99(4-6):425-36. PubMed ID: 16750616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation in acute CNS injury: a focus on the role of substance P.
    Corrigan F; Vink R; Turner RJ
    Br J Pharmacol; 2016 Feb; 173(4):703-15. PubMed ID: 25827155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
    Khansari PS; Halliwell RF
    Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
    Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
    Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies.
    Hazell AS
    Neurochem Int; 2007 Jun; 50(7-8):941-53. PubMed ID: 17576023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential for substance P antagonists as anti-cancer agents in brain tumours.
    Harford-Wright E; Lewis KM; Vink R
    Recent Pat CNS Drug Discov; 2013 Apr; 8(1):13-23. PubMed ID: 23477306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of haematoma, brain injury, and secondary insult on brain swelling in traumatic acute subdural haemorrhage.
    Sawauchi S; Abe T
    Acta Neurochir (Wien); 2008 Jun; 150(6):531-6; discussion 536. PubMed ID: 18493704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.